Home › Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

Mar 16, 2018

NEW YORK (GenomeWeb) – Foundation Medicine said today that it has partnered with Chugai Pharmaceutical, a member of the Roche Group, to broaden patient access to its cancer genomic profiling services in Japan.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Cancer

  1. Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs

  2. Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

    Premium

  3. Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers

  4. Guardant Health to Launch Cell-Free DNA Assay for Cancer Recurrence Monitoring in 2019

    Premium

  5. SABCS 2018 Features Molecular Diagnostics Research

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.